4 June 2020
Today, world leaders have come together at Gavi’s donor pledging conference, the Global Vaccine Summit, which aimed to mobilise at least $7.4 billion towards Gavi’s next strategic cycle (2021-25). Gavi has received $8.8 billion in contributions which surpasses that goal and will protect the next generation through vaccination.
In response, the British Society for Immunology has released the following statement.
Dr Doug Brown, Chief Executive of the British Society for Immunology, said:
“The replenishment of funding for Gavi, the Vaccine Alliance – going above and beyond their initial goal – is a truly impressive achievement and one that will not only advance global health but will also bring economic stability and allow our societies to thrive. As the British Society for Immunology’s recent report shows, long-term strategic investment in vaccine research is crucial to secure global health against current and emerging disease. Today’s more than successful replenishment of Gavi will ensure that any new, as well as current, vaccines will reach those most in need.
“Vaccination saves and transforms lives through preventing the spread of infectious diseases. The renewed and additional funding will allow 300 million children to be immunised, saving more than 7 million lives. By sustaining global health systems and immunisation programmes, the world will also be better prepared to tackle the ongoing pandemic and introduce a vaccine for COVID-19, making our world a more stable and safer place to live.”
The British Society for Immunology recently released a new report highlighting the role of UK vaccine research in improving global public health. You can download a full copy of the report here.